ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SRPT Sarepta Therapeutics Inc New

127.39
3.14 (2.53%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
3.14 2.53% 127.39 19:52:39
Open Price Low Price High Price Close Price Prev Close
122.935 121.80 130.61 127.39 124.25
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/202408:30BWSarepta Therapeutics to Announce First Quarter 2024..
3/29/202416:00BWSarepta Therapeutics Announces Inducement Grants Under..
3/08/202417:38EDGAR2Form 144 - Report of proposed sale of securities
3/06/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202417:34EDGAR2Form 144 - Report of proposed sale of securities
3/04/202408:30BWSarepta Therapeutics to Present at Upcoming Investor..
3/01/202419:55EDGAR2Form 144 - Report of proposed sale of securities
3/01/202419:42EDGAR2Form 144 - Report of proposed sale of securities
3/01/202416:47EDGAR2Form 144 - Report of proposed sale of securities
2/29/202418:16BWSarepta Therapeutics Announces Inducement Grants Under..
2/29/202409:00BWSarepta Therapeutics Announces Call for Applications for the..
2/28/202416:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
2/21/202408:30BWSarepta Therapeutics to Announce Fourth Quarter and..
2/16/202407:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
2/13/202413:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202418:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/31/202418:29BWSarepta Therapeutics Announces Inducement Grants Under..
1/29/202407:00BWSarepta Therapeutics Announces Positive Data from Part B of..
1/16/202409:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
1/08/202412:08EDGAR2Form 8-K - Current report
1/08/202411:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
1/02/202408:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
12/29/202318:27BWSarepta Therapeutics Announces Inducement Grants Under..
12/22/202308:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
12/05/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202318:34BWSarepta Therapeutics Announces Inducement Grants Under..
11/20/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202308:30BWSarepta Therapeutics to Present at the UBS Biopharma..
11/01/202316:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
11/01/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202319:02BWSarepta Therapeutics Announces Inducement Grants Under..
10/30/202317:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..
10/30/202316:01BWSarepta Therapeutics Announces Topline Results from EMBARK,..
10/25/202308:30BWSarepta Therapeutics to Announce Third Quarter 2023..

Your Recent History

Delayed Upgrade Clock